Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MNPR | AZN | AMGN | GILD | BMY |
| Company | Monopar Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 61.42 | 193.96 | 368.24 | 146.52 | 60.13 |
| High | 64.87 | 193.96 | 368.78 | 146.71 | 60.81 |
| Low | 60.43 | 192.26 | 363.90 | 143.27 | 59.75 |
| Latest | 63.30 | 192.60 | 364.62 | 144.82 | 60.70 |
| Change | +1.77 | +0.59 | -1.63 | -0.39 | +0.99 |
| % Change | +2.88% | +0.31% | -0.45% | -0.27% | +1.66% |
| Volume | 70,758 | 305,049 | 313,741 | 787,676 | 2,608,924 |
| 20-Day Average Volume | 176,124 | 1,877,292 | 2,400,117 | 6,177,090 | 11,636,723 |
| Previous Close | 61.53 | 192.01 | 366.25 | 145.21 | 59.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 56.74 | 200.04 | 375.93 | 147.47 | 60.72 |
| 20-Day Raw Stochastic | 90.65% | 15.88% | 12.27% | 18.24% | 51.24% |
| 20-Day Relative Strength | 55.25 | 47.60 | 50.16 | 52.17 | 56.44 |
| Weighted Alpha | +23.47 | +32.09 | +22.45 | +39.68 | +12.85 |
| Today's Opinion | 16% Sell | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 24% Sell | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.41% since 03/10/26 | -0.99% since 03/10/26 | -2.76% since 03/10/26 | -2.32% since 03/10/26 | +0.88% since 03/10/26 |
| Low | 54.22 on 03/12/26 | 189.43 on 03/13/26 | 364.24 on 03/17/26 | 142.68 on 03/16/26 | 58.32 on 03/12/26 |
| High | 64.74 on 03/17/26 | 194.83 on 03/11/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | +17.00% since 02/17/26 | -7.84% since 02/17/26 | -2.22% since 02/17/26 | -6.54% since 02/17/26 | +0.51% since 02/17/26 |
| Low | 50.73 on 03/03/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.68 on 03/16/26 | 58.32 on 03/12/26 |
| High | 64.74 on 03/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -6.31% since 12/17/25 | +7.42% since 12/17/25 | +11.98% since 12/17/25 | +19.57% since 12/17/25 | +13.28% since 12/17/25 |
| Low | 50.73 on 03/03/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 76.13 on 01/23/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -4.82% since 09/17/25 | +24.25% since 09/17/25 | +32.89% since 09/17/25 | +29.26% since 09/17/25 | +31.44% since 09/17/25 |
| Low | 50.73 on 03/03/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 105.00 on 10/06/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 411,180 | 297,789,824 | 197,433,664 | 180,266,752 | 121,597,856 |
| Shares Outstanding, K | 6,683 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -15,590,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,440,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.58 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 11/13/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/30/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.73 | 16.76 | 17.79 | 9.61 |